1. Liang, Lu, He, Hua, Jiang, Shiyao, Jiang, Yiqun, Cong, Li. 2022. TIAM2 Contributes to Osimertinib Resistance, Cell Motility, and Tumor-Associated Macrophage M2-like Polarization in Lung Adenocarcinoma. In International journal of molecular sciences, 23, . doi:10.3390/ijms231810415. https://pubmed.ncbi.nlm.nih.gov/36142328/
2. Zhang, Guizhen, Liu, Liwen, Li, Jianhao, Sun, Ranran, Cui, Guangying. 2023. NSUN2 stimulates tumor progression via enhancing TIAM2 mRNA stability in pancreatic cancer. In Cell death discovery, 9, 219. doi:10.1038/s41420-023-01521-y. https://pubmed.ncbi.nlm.nih.gov/37393317/
3. Cooke, Mariana, Kreider-Letterman, Gabriel, Baker, Martin J, García-Mata, Rafael, Kazanietz, Marcelo G. . FARP1, ARHGEF39, and TIAM2 are essential receptor tyrosine kinase effectors for Rac1-dependent cell motility in human lung adenocarcinoma. In Cell reports, 37, 109905. doi:10.1016/j.celrep.2021.109905. https://pubmed.ncbi.nlm.nih.gov/34731623/
4. Zhao, Zheng-Yuan, Han, Chen-Guang, Liu, Jun-Tao, Wang, Yi, Cheng, Li-Ya. . TIAM2 enhances non-small cell lung cancer cell invasion and motility. In Asian Pacific journal of cancer prevention : APJCP, 14, 6305-9. doi:. https://pubmed.ncbi.nlm.nih.gov/24377522/
5. Chen, Jia-Shing, Su, Ih-Jen, Leu, Yu-Wei, Young, Kung-Chia, Sun, H Sunny. 2011. Expression of T-cell lymphoma invasion and metastasis 2 (TIAM2) promotes proliferation and invasion of liver cancer. In International journal of cancer, 130, 1302-13. doi:10.1002/ijc.26117. https://pubmed.ncbi.nlm.nih.gov/21469146/
6. Wong, Regina Wan Ju, Ngoc, Phuong Cao Thi, Leong, Wei Zhong, Ishida, Takashi, Sanda, Takaomi. 2017. Enhancer profiling identifies critical cancer genes and characterizes cell identity in adult T-cell leukemia. In Blood, 130, 2326-2338. doi:10.1182/blood-2017-06-792184. https://pubmed.ncbi.nlm.nih.gov/28978570/
智鼠故事 
